首页> 美国卫生研究院文献>other >Blind prediction performance of RosettaAntibody 3.0: Grafting relaxation kinematic loop modeling and full CDR optimization
【2h】

Blind prediction performance of RosettaAntibody 3.0: Grafting relaxation kinematic loop modeling and full CDR optimization

机译:RosettaAntibody 3.0的盲预测性能:嫁接松弛运动学循环建模和完整CDR优化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antibody Modeling Assessment II (AMA-II) provided an opportunity to benchmark RosettaAntibody on a set of eleven unpublished antibody structures. RosettaAntibody produced accurate, physically realistic models, with all framework regions and 42 of the 55 non-H3 CDR loops predicted to under an Ångström. The performance is notable when modeling H3 on a homology framework, where RosettaAntibody produced the best model among all participants for four of the eleven targets, two of which were predicted with sub-Ångström accuracy. To improve RosettaAntibody, we pursued the causes of model errors. The most common limitation was template unavailability, underscoring the need for more antibody structures and/or better de novo loop methods. In some cases, better templates could have been found by considering residues outside of the CDRs. De novo CDR H3 modeling remains challenging at long loop lengths, but constraining the C-terminal end of H3 to a kinked conformation allows near-native conformations to be sampled more frequently. We also found that incorrect VL–VH orientations caused models with low H3 RMSDs to score poorly, suggesting that correct VL–VH orientations will improve discrimination between near-native and incorrect conformations. These observations will guide the future development of RosettaAntibody.
机译:抗体建模评估II(AMA-II)提供了一个机会,可以对RosettaAntibody的11种未公开抗体结构进行基准测试。 RosettaAntibody产生了精确的,物理上真实的模型,所有框架区域和55个非H3 CDR环中的42个预测在Ångström之下。在同源性框架上对H3建模时,该性能非常出色,其中RosettaAntibody在所有参与者中为11个目标中的4个产生了最佳模型,其中两个目标的精确度低于Ångström。为了改进RosettaAntibody,我们研究了模型错误的原因。最常见的限制是模板不可用,从而强调了对更多抗体结构和/或更好的从头环方法的需求。在某些情况下,可以通过考虑CDR之外的残基找到更好的模板。从头开始CDR H3建模在长环长度上仍然具有挑战性,但是将H3的C末端限制为纽结构象可允许更频繁地采样近本构象。我们还发现,不正确的VL–VH方向导致具有较低H3 RMSD的模型得分很低,这表明正确的VL–VH方向将改善近乎自然构象和错误构象之间的区别。这些观察将指导RosettaAntibody的未来发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号